2013
DOI: 10.11106/jkta.2013.6.1.69
|View full text |Cite
|
Sign up to set email alerts
|

Clinicopathologic Characteristics of Papillary Microcarcinoma in the Elderly

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2014
2014
2018
2018

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 29 publications
0
2
0
1
Order By: Relevance
“…The variants reported in young PTC patients include the diffuse sclerosing variant (41.2%, predominant), conventional PTC (38.2%), follicular (2.9%), and cribriform-morular variants (1.5%) 10. PTC in young patients is more likely to have ETE (62.3%), lymph node metastasis (72%), and distant metastasis (23%) than that in adults: adults have ETE (31.2-33%) and lymph node metastasis (32.1-40.9%) 12. The most common metastatic site is the lung (16.2%).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The variants reported in young PTC patients include the diffuse sclerosing variant (41.2%, predominant), conventional PTC (38.2%), follicular (2.9%), and cribriform-morular variants (1.5%) 10. PTC in young patients is more likely to have ETE (62.3%), lymph node metastasis (72%), and distant metastasis (23%) than that in adults: adults have ETE (31.2-33%) and lymph node metastasis (32.1-40.9%) 12. The most common metastatic site is the lung (16.2%).…”
Section: Discussionmentioning
confidence: 99%
“… 10 PTC in young patients is more likely to have ETE (62.3%), lymph node metastasis (72%), and distant metastasis (23%) than that in adults: adults have ETE (31.2-33%) and lymph node metastasis (32.1-40.9%). 12 The most common metastatic site is the lung (16.2%). In view of these aggressive features at the time of diagnosis, closer and more extensive workups should be performed in young patients than in elder patients to ensure exact diagnosis and appropriate early management.…”
Section: Discussionmentioning
confidence: 99%
“…Микрокарциномы щитовидной железы определятся согласно классификации ВОЗ как папиллярные раки щитовидной железы до 1 см в наибольшем размере [1]. В связи с широким применением в клинической практике тонкоигольной аспирационной биопсии (ТАПБ), микрокарциномы стали составлять около 40 % [2], по данным отдельных авторов -до 61,48 % [3] от диагностируемых раков ЩЖ. До сих пор продолжает быть актуальным исследование характера течения микрокарцином ЩЖ.…”
Section: Introductionunclassified